FDA Grants Accelerated Approval to Replimune's Tudriqev for Advanced Cutaneous Melanoma
Replimune's cancer therapy Tudriqev has received FDA accelerated approval as a treatment option for patients diagnosed with advanced cutaneous melanoma.
Technology news and prediction markets.
Replimune's cancer therapy Tudriqev has received FDA accelerated approval as a treatment option for patients diagnosed with advanced cutaneous melanoma.
ByteDance is building a large-scale AI model to challenge leaders like Anthropic, signaling a significant push into the high-end generative AI market.
A judge has mandated that Meta pay $942 million in damages to address the negative mental health impacts its platforms have had on children.
Scientists have successfully used AI-driven genomic models to create functional, synthetic viruses, marking a significant advancement in synthetic biology.
OpenAI has asked a court to dismiss Apple's trade secrets lawsuit, arguing the litigation is a retaliatory tactic to prevent employees from joining competitors.
Tesla and SpaceX are partnering to construct a massive $16.8 billion semiconductor manufacturing facility near Houston to bolster chip supply chains.
T-Mobile's CEO argues that Starlink's direct-to-cell technology is too limited in capacity to significantly disrupt the traditional mobile carrier market.
OpenAI is working on its first dedicated hardware device, marking the company's potential expansion from AI software models into consumer electronics.
A security flaw in Coldcard hardware wallets allowed attackers to drain 1,596 Bitcoin, raising concerns about entropy and supply chain security in crypto.
Google has open-sourced an AI model capable of predicting hurricane tracks and intensity up to 15 days in advance to aid early warning efforts.
The same prediction markets that move the headlines above — priced live across Kalshi and the Polymarket family. Filter by sport to dig in.